IMVAMUNE
IMVAMUNE
Restricted Access
DIN Number
02416638
Drug Class
Human
Market Date
Jun 15, 2015
Company
HC
bavarian nordic as
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02416638
AIG Number0155011001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BX01 SMALLPOX AND MONKEYPOX VACCINES
Product Specifications
Dosage FormSuspension
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
MODIFIED VACCINIA VIRUS (ANKARA-BAVARIAN NORDIC)Active
Strength: 50000000 CCID50 / 0.5 ML
Monograph: MODIFIED VACCINIA VIRUS (ANKARA-BAVARIAN NORDIC)